A Study Comparing Rapid Acting Intramuscular Olanzapine and Placebo in Agitated Patients With Schizophrenia
Clinical trial NCT00640510 · COMPLETED
Trial details
- NCT number
- NCT00640510
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-03-01
- Primary completion
- 2008-07-01
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.